Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Circulation

• Publication date

  1999-04-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.99.16.2079PMID 10217645
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

  1998cited by this paper
• Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction.

  1998cited by this paper
• Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein.

  1997cited by this paper
• Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group.

  1997cited by this paper
• Elevated Chlamydia pneumoniae Antibodies, Cardiovascular Events, and Azithromycin in Male Survivors of Myocardial Infarction

  1997cited by this paper
• Response to local inflammation of IL-1 beta-converting enzyme- deficient mice.

  1997cited by this paper
• Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1997cited by this paper
• Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.

  1997cited by this paper
• Plasma protein acute-phase response in unstable angina is not induced by ischemic injury.

  1996cited by this paper
• Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

  1996cited by this paper
• Elevated levels of interleukin-6 in unstable angina.

  1996cited by this paper
• Biologic basis for interleukin-1 in disease.

  1996cited by this paper
• Episodic activation of the coagulation system in unstable angina does not elicit an acute phase reaction.

  1996cited by this paper
• Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury.

  1995cited by this paper
• Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice.

  1995cited by this paper
• Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

  1994cited by this paper
• Interleukin-1 induces interleukin-8 secretion from endothelial cells by a juxtacrine mechanism.

  1994cited by this paper
• The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

  1994cited by this paper
• Initial evaluation of human recombinant interleukin‐1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open‐label, placebocontrolled multicenter trial

  1994cited by this paper
• Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients.

  1994cited by this paper
• Relation of Helicobacter pylori infection and coronary heart disease.

  1994cited by this paper
• Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

  1994cited by this paper
• Platelets in ulcerative colitis and Crohn's disease express functional interleukin‐1 and interleukin‐8 receptors

  1994cited by this paper
• Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia.

  1994cited by this paper
• Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients

  1994cited by this paper
• Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event.

  1993cited by this paper
• Cytokine regulation of granulocyte-macrophage colony stimulating factor and macrophage colony-stimulating factor production in human arterial smooth muscle cells.

  1993cited by this paper
• Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome

  1993cited by this paper
• Measuring circulating cytokines.

  1993cited by this paper
• Interleukin-1α As a Factor in Occlusive Vascular Disease

  1992cited by this paper
• Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease.

  1992cited by this paper
• Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study

  1992cited by this paper
• Interleukin‐1 (IL‐1) receptor blockade reduces endotoxin and Borrelia burgdorferi‐stimulated IL‐8 synthesis in human mononuclear cells

  1992cited by this paper
• Interleukin-1 alpha as a factor in occlusive vascular disease.

  1992cited by this paper
• Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated.

  1991cited by this paper
• Production of interleukin-1-receptor antagonist during experimental endotoxaemia.

  1991cited by this paper
• Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production

  1991cited by this paper
• Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever.

  1990cited by this paper
• In vivo evidence that the rise in plasma IL 6 following injection of a fever-inducing dose of LPS is mediated by IL 1 beta.

  1990cited by this paper
• Membrane IL-1: IL-1 alpha precursor binds to the plasma membrane via a lectin-like interaction.

  1989cited by this paper
• Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage.

  1989cited by this paper
• Activated platelets express IL-1 activity.

  1989cited by this paper
• Identification of a membrane-associated interleukin 1 in macrophages.

  1985cited by this paper

• Valor pronostico de una curva de PCR en los sindromes isquemicos agudos sin supradesnivel del ST

  2026cites this paper
• Clinical and Inflammatory Outcomes of Rotational Atherectomy in Calcified Coronary Lesions: A Systematic Review and Meta-Analysis

  2025cites this paper
• IL-18 potentiates platelet activation and thrombosis through IL-18Rα-dependent MAPKs and PI3K/Akt signaling.

  2025cites this paper
• Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large‐scale, propensity‐matched global retrospective cohort study

  2024cites this paper
• The Role of Pro-Inflammatory Cytokines in the Pathogenesis of Cardiovascular Disease

  2024cites this paper
• Increased expression of ER stress, inflammasome activation, and mitochondrial biogenesis-related genes in peripheral blood mononuclear cells in major depressive disorder

  2024cites this paper
• IL-1 receptor antagonist: etiological and drug delivery systems overview

  2024cites this paper
• Biomarkers of Cardiovascular Risk in Patients With Rheumatoid Arthritis: Results From the TARGET Trial

  2024cites this paper
• The association of inflammatory biomarkers and long-term clinical outcomes in older adults with non-ST elevation acute coronary syndrome.

  2024cites this paper
• Adipokines in the Crosstalk between Adipose Tissues and Other Organs: Implications in Cardiometabolic Diseases

  2024cites this paper
• Cholesterol and Cytokines: Molecular Links to Atherosclerosis and Carcinogenesis

  2024cites this paper
• Long-term harm associated with renal artery stents in a temporally distant time after the renal function is gone

  2023cites this paper
• A machine-learning based bio-psycho-social model for the prediction of non-obstructive and obstructive coronary artery disease

  2023cites this paper
• IL-1ra treatment prevents chronic social defeat stress-induced depression-like behaviors and glutamatergic dysfunction via the upregulation of CREB-BDNF.

  2023cites this paper
• Immunophenotyping of Monocyte Migration Markers and Therapeutic Effects of Selenium on IL-6 and IL-1β Cytokine Axes of Blood Mononuclear Cells in Preoperative and Postoperative Coronary Artery Disease Patients

  2023cites this paper
• A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarcinoma.

  2023cites this paper
• Effect of smoking on interleukin 6, tumor necrosis factor and C-reactive protein in hypertensive patients

  2023cites this paper
• Key Roles of Inflammation in Atherosclerosis: Mediators Involved in Orchestrating the Inflammatory Response and Its Resolution in the Disease Along with Therapeutic Avenues Targeting Inflammation.

  2022cites this paper
• Potential role for pentoxifylline as an anti-inflammatory drug for patients with acute coronary syndrome

  2022cites this paper
• GLUT-1/PKM2 loop dysregulation in patients with non-ST-segment elevation myocardial infarction promotes metainflammation.

  2022cites this paper
• Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond

  2021cites this paper
• TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 Infection

  2021cites this paper
• Association between Biomarkers of Oxidative Stress and Inflammation with Cardiac Necrosis and Heart Failure in Non-ST Segment Elevation Myocardial Infarction Patients and Various Degrees of Kidney Function

  2021cites this paper
• Association Between Inflammatory Cytokines and Long Term Adverse Outcomes in Acute Coronary Syndrome: A Systemic Review

  2021cites this paper
• The Effect of Acute Bronchitis on Blood Pressure

  2021cites this paper
• Increased serum IL-6 is predictive of long-term cardiovascular events in high-risk patients submitted to coronary angiography: an observational study

  2021cites this paper
• Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodeling.

  2021cites this paper
• A primer on cytokines.

  2021cites this paper
• Metoprolol combined with nicorandil on unstable angina pectoris can reduce incidence of cardiovascular events and inflammatory reactions.

  2021cites this paper
• Mast Cells Mediate Skin Inflammation in Psoriasis: A New Therapeutic Approach with the Anti- inflammatory Cytokines IL-37, IL-38 or IL-1Ra INTRODUCTION Approximately 3% of the population of the United States of America and 2% of the whole world

  2021cites this paper
• Candidates for smart cardiovascular medical device coatings: A comparative study with endothelial and smooth muscle cells.

  2021cites this paper
• An Overview of Human Pericardial Space and Pericardial Fluid.

  2021cites this paper
• Targeting the Oxytocinergic System: A Possible Pharmacological Strategy for the Treatment of Inflammation Occurring in Different Chronic Diseases

  2021cites this paper
• Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra

  2021cites this paper
• The link between resistin, systemic low-grade inflammation and obstructive sleep apnea

  2021cites this paper
• A Proteomics- and Metabolomics-Based Study Revealed That Disorder of Palmitic Acid Metabolism by Aconitine Induces Cardiac Injury.

  2020cites this paper
• Investigating the multi-target pharmacological mechanism of danhong injection acting on unstable angina by combined network pharmacology and molecular docking

  2020cites this paper
• ФАКТОРЫ РАЗВИТИЯ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ / FACTORS OF DEVELOPMENT OF CARDIOVASCULAR DISEASES

  2020cites this paper
• Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events.

  2020cites this paper
• From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19

  2020cites this paper
• Effectiveness of testosterone therapy in hypogonadal patients and its controversial adverse impact on the cardiovascular system

  2020cites this paper
• Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease.

  2020cites this paper
• Interleukin-7 and interleukin-15 drive CD4+CD28null T lymphocyte expansion and function in patients with acute coronary syndrome

  2020cites this paper
• IL-1Rahigh-IL-4low-IL-13low: A Novel Plasma Cytokine Signature Associated with Olfactory Dysfunction in Older US Adults.

  2020cites this paper
• Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2?

  2020cites this paper
• OP-CVRE200209 1..14

  2020cites this paper
• The role of inflammation and oxidative stress in depression and cardiovascular disease

  2020cites this paper
• Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications

  2020cites this paper
• Anti-Atherosclerosis Effect of Angong Niuhuang Pill via Regulating Th17/Treg Immune Balance and Inhibiting Chronic Inflammatory on ApoE-/- Mice Model of Early and Mid-Term Atherosclerosis

  2020cites this paper
• Inflammation in Chronic Kidney Disease

  2020cites this paper
• High low‐density lipoprotein cholesterol as an independent risk factor for coronary restenosis in hemodialysis patients undergoing percutaneous coronary interventions

  2020cites this paper
• Anticytokine Immune Therapy and Atherothrombotic Cardiovascular Risk.

  2019cites this paper
• Testosterone replacement therapy and cardiovascular risk

  2019cites this paper
• Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis.

  2019cites this paper
• Long- and short-term association of low-grade systemic inflammation with cardiovascular mortality in the LURIC study

  2019cites this paper
• Derivation and validation of a simple inflammation-based risk score system for predicting in-hospital mortality in acute coronary syndrome patients.

  2019cites this paper
• ATVB IN FOCUS: Clinically Available Immunotherapies: Expected Impact on Cardiovascular Disease

  2019cites this paper
• Protective Actions of Oxytocin on Aortic Wistar and SHR VSMCs

  2019cites this paper
• Interleukin-37 is increased in peripheral blood mononuclear cells of coronary heart disease patients and inhibits the inflammatory reaction

  2019cites this paper
• Unmet needs in the management of cardiovascular risk in inflammatory joint diseases

  2019cites this paper
• Reduced concentrations of the B cell cytokine interleukin 38 are associated with cardiovascular disease risk in overweight subjects

  2019cites this paper
• Free light chains a novel biomarker of cardiovascular disease. A pilot study.

  2019cites this paper
• herramientas en la estratificación del riesgo cardiovascular

  2019cites this paper
• Epigenetic Regulation of Vascular Smooth Muscle Cells by Histone H3 Lysine 9 Dimethylation Attenuates Target Gene-Induction by Inflammatory Signaling

  2019cites this paper
• Interleukin-1 Mediated Autoinflammation from Heart Disease to Cancer

  2019cites this paper
• Influence of Interleukin-6 (IL-6) Promoter Gene Polymorphisms (−174G>C, −572G>C, and −597G>A) on IL-6 Plasma Levels and Their Impact in the Development of Acute Ischemic Stroke in Young Indians

  2019cites this paper
• Imaging residual inflammatory cardiovascular risk.

  2019cites this paper
• Treatment of Inflammatory Diseases with IL-1 Blockade

  2018cites this paper
• Interleukin-1 receptor antagonist levels predict favorable outcome after bermekimab, a first-in-class true human interleukin-1α antibody, in a phase III randomized study of advanced colorectal cancer

  2018cites this paper
• Edinburgh Research Explorer Investigation of the effect of Interleukin-1 receptor antagonist (IL-Ira) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study) on in

  2018cites this paper
• Interleukin-6 Level among Shift and Night Workers in Japan: Cross-Sectional Analysis of the J-HOPE Study

  2018cites this paper
• A modern approach to interleukin-6

  2018cites this paper
• Role of serum interleukin-6 in heart failure

  2018cites this paper
• High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis

  2018cites this paper
• The role of regulatory cytokines in formation and progressing of ischemic heart disease associated without assessment hyperericemia

  2018cites this paper
• Ventajas clínicas del bloqueo terapéutico de la IL-6

  2018cites this paper
• Recambio valvular aórtico aislado en pacientes mayores de 75 años mediante abordaje mínimamente invasivo y bioprótesis sin sutura

  2018cites this paper
• Ticagrelor, a molecular breakthrough to modulate cytokine network in the treatment of acute myocardial infarction "perspective and prospective"

  2018cites this paper
• Chemokine RANTES is increased at early stages of atherosclerosis severity

  2018cites this paper
• Examining the Role of and Treatment Directed at IL-1β in Atherosclerosis

  2018cites this paper
• CANTOS: a seductive song with several verses

  2018cites this paper
• Metabolites of Hypoxic Cardiomyocytes Induce the Migration of Cardiac Fibroblasts

  2017cites this paper
• Where Does Inflammation Fit?

  2017cites this paper
• Novel markers of plaque rupture in patients with chest pain

  2017cites this paper
• The Roles of Hypoxia Signaling in the Pathogenesis of Cardiovascular Diseases

  2017cites this paper
• ISCHEMIC HEART DISEASE Circadian Variations in Proinflammatory Cytokine Concentrations in Acute Myocardial Infarction

  2017cites this paper
• Ischemic heart disease and rheumatoid arthritis: Do inflammatory cytokines have a role?

  2017cites this paper
• Inflammatory processes in cardiovascular disease: a route to targeted therapies

  2017cites this paper
• Proinflammatory cytokines remain elevated despite long‐term remission in Cushing's disease: a prospective study

  2017cites this paper
• Interleukin-6 in cardiac surgery

  2017cites this paper
• Investigation of Biochemical Composition and Vasomotor Effect of Human Pericardial Fluid

  2016cites this paper
• Relationship between site of myocardial infarction, left ventricular function and cytokine levels in patients undergoing coronary artery surgery.

  2016cites this paper
• Novel therapeutic concepts Inflammatory cytokines in atherosclerosis : current therapeutic approaches

  2016cites this paper
• Systemic Inflammation in Unstable Angina s Largely Unrelated to the Atherothrombotic Burden

  2016cites this paper
• Inflammatory markers in ST-elevation acute myocardial infarction

  2016cites this paper
• A Plaque Disruption Index Identifies Patients with Non-STE-Type 1 Myocardial Infarction within 24 Hours of Troponin Positivity

  2016cites this paper
• The rs2228145 polymorphism in the interleukin-6 receptor and its association with long-term prognosis after myocardial infarction in a pilot study

  2016cites this paper
• Cardiovascular disease in inflammatory rheumatic diseases.

  2016cites this paper
• The Recent Advances in the Serological Detection of Acute Myocardial Infarction

  2016cites this paper
• Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction

  2016cites this paper